<VariationArchive VariationID="100523" VariationName="NM_003590.5(CUL3):c.1376_1377+4del" VariationType="Deletion" Accession="VCV000100523" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-08" DateCreated="2014-07-07" MostRecentSubmission="2014-07-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="106400" VariationID="100523">
      <GeneList>
        <Gene Symbol="CUL3" FullName="cullin 3" GeneID="8452" HGNC_ID="HGNC:2553" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q36.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="224470150" stop="224585363" display_start="224470150" display_stop="224585363" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="225334866" stop="225450113" display_start="225334866" display_stop="225450113" Strand="-" />
          </Location>
          <OMIM>603136</OMIM>
          <Haploinsufficiency last_evaluated="2018-01-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CUL3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-01-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CUL3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_003590.5(CUL3):c.1376_1377+4del</Name>
      <CanonicalSPDI>NC_000002.12:224503647:TTACCTTTA:TTA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q36.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="224503648" stop="224503653" display_start="224503648" display_stop="224503653" variantLength="6" positionVCF="224503647" referenceAlleleVCF="CTTACCT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="225368365" stop="225368370" display_start="225368365" display_stop="225368370" variantLength="6" positionVCF="225368364" referenceAlleleVCF="CTTACCT" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>INT9_(-2to+4)del</Name>
        <Name>K459fs</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.225368368_225368373del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.225368368_225368373del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.224503651_224503656del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.224503651_224503656del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032169.1" sequenceAccession="NG_032169" sequenceVersion="1" change="g.86745_86750del">
            <Expression>NG_032169.1:g.86745_86750del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001257197.2" sequenceAccession="NM_001257197" sequenceVersion="2" change="c.1178_1179+4del">
            <Expression>NM_001257197.2:c.1178_1179+4del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003590.5" sequenceAccession="NM_003590" sequenceVersion="5" change="c.1376_1377+4del" MANESelect="true">
            <Expression>NM_003590.5:c.1376_1377+4del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001257198.2" sequenceAccession="NM_001257198" sequenceVersion="2" change="c.1394_1395+4del">
            <Expression>NM_001257198.2:c.1394_1395+4del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003590.3" sequenceAccession="NM_003590" sequenceVersion="3" change="c.1376_1377+4delAGGTAA">
            <Expression>NM_003590.3:c.1376_1377+4delAGGTAA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA269963" DB="ClinGen" />
        <XRef Type="rs" ID="199469657" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003590.5(CUL3):c.1376_1377+4del AND Pseudohypoaldosteronism type 2A" Accession="RCV000128495" Version="3">
        <ClassifiedConditionList TraitSetID="6355">
          <ClassifiedCondition DB="MedGen" ID="C1840389">Pseudohypoaldosteronism type 2A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2014-07-07" MostRecentSubmission="2014-07-07">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="6355" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3402" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">HYPERTENSIVE HYPERKALEMIA, FAMILIAL</ElementValue>
                <XRef Type="MIM" ID="145260" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pseudohypoaldosteronism type 2A</ElementValue>
                <XRef ID="MONDO:0007772" DB="MONDO" />
                <XRef ID="703254001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperpotassemia and hypertension familial</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gordon hyperkalemia-hypertension syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Chloride shunt syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PHA2A</ElementValue>
                <XRef Type="MIM" ID="145260" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PHA2</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16775" />
                <XRef ID="16775" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Pseudohypoaldosteronism type II (PHAII) is characterized by hyperkalemia despite normal glomerular filtration rate (GFR) and frequently by hypertension. Other associated findings in both children and adults include hyperchloremia, metabolic acidosis, and suppressed plasma renin levels. Aldosterone levels are variable, but are relatively low given the degree of hyperkalemia (elevated serum potassium is a potent stimulus for aldosterone secretion). Hypercalciuria is well described.</Attribute>
                <XRef ID="NBK65707" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22073419</ID>
                <ID Source="BookShelf">NBK65707</ID>
              </Citation>
              <XRef ID="757" DB="Orphanet" />
              <XRef ID="88938" DB="Orphanet" />
              <XRef ID="C1840389" DB="MedGen" />
              <XRef ID="MONDO:0007772" DB="MONDO" />
              <XRef Type="MIM" ID="145260" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="210195" SubmissionDate="2012-01-06" DateLastUpdated="2014-07-07" DateCreated="2014-07-07">
        <ClinVarSubmissionID localKey="NM_003590.3:c.1376_1377+4delAGGTAA|LIFTON_LAB_YALE_UNIV" />
        <ClinVarAccession Accession="SCV000119145" DateUpdated="2014-07-07" DateCreated="2014-07-07" Type="SCV" Version="1" SubmitterName="Richard Lifton Laboratory, Yale University School of Medicine" OrgID="500126" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>pathogenic</GermlineClassification>
          <Comment>Converted during submission to Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>K459fs</Name>
            <Name>INT9_(-2to+4)del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003590.3:c.1376_1377+4delAGGTAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Pseudohypoaldosteronism, type 2</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="145260" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>dominant;intron 9 splice donor</Comment>
        <SubmissionNameList>
          <SubmissionName>PHAII_BOYDEN_2011</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="210195" TraitType="Disease" MappingType="Name" MappingValue="Pseudohypoaldosteronism, type 2" MappingRef="Preferred">
        <MedGen CUI="C1449844" Name="Pseudohypoaldosteronism, type 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

